# US 2019/0167565 A1 · Probiotic treatment of skin diseases, disorders, and infections: formulations methods and systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167565 A1
- Document ID: US20190167565A1
- Status: Published application
- Kind: A1
- Application number: 16/271,469
- Filed: 2019-02-08
- Published: 2019-06-06
- Earliest claimed: 2015-11-19
- Assignees: Beauty Biolabs LLC
- Applicants: Beauty Biolabs LLC
- Inventors: Marc M. Baum; Janelle M. Baum
- Web page: https://patentgrep.com/patent/US20190167565A1

## CPC

- A61K 8/342: {Alcohols having more than seven atoms in an unbroken chain}
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/36: Carboxylic acids; Salts or anhydrides thereof
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/37: Esters of carboxylic acids
- A61K 8/60: Sugars; Derivatives thereof
- A61K 8/73: Polysaccharides
- A61K 8/891: saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61Q 5/006: {Antidandruff preparations}
- A61K 2800/884: Sequential application
- A61K 2800/92: Oral administration
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention teaches compositions, methods and kits for treating skin conditions, including dandruff. In various embodiments, the compositions include an effective amount of one or more probiotic microorganism of vaginal origin and/or a fraction thereof and/or a component of the metabolome for preventing and/or treating skin disorders of the scalp.

## Claims

### Claim 1

A method for reducing dandruff of the scalp in a subject in need thereof, comprising administering to the subject an effective amount of a composition comprising:
one or more Lactobacillus spp. isolated from human clinical vaginal specimens;
one or more of D,L-lactic acid, L-lactic acid, or D-lactic acid; and
one or more cell lysate components of the Lactobacillus spp.,
so as to reduce dandruff in the subject.

### Claim 2 (depends on 1)

The method of claim 1, wherein the Lactobacillus spp. have undergone less than 6 subcultures.

### Claim 3 (depends on 1)

The method of claim 1, wherein the Lactobacillus spp. reduces the growth of Malassezia spp.

### Claim 4 (depends on 1)

The method of claim 1, wherein the Lactobacillus spp. inhibits the growth of Malassezia spp.

### Claim 5 (depends on 1)

The method of claim 1, wherein the composition further comprises butyric acid.

### Claim 6 (depends on 1)

The method of claim 1, wherein the composition is administered orally.

### Claim 7 (depends on 1)

The method of claim 1, wherein the composition is administered topically.

### Claim 8 (depends on 1)

The method of claim 1, wherein the composition is administered to the subject's skin.

### Claim 9 (depends on 1)

The method of claim 1, wherein the composition is administered to the subject's scalp.

### Claim 10 (depends on 1)

The method of claim 1, wherein the composition further comprises butyric acid, glucose and glycogen.

### Claim 11 (depends on 1)

The method of claim 1, wherein the composition further comprises butyric acid, glucose, glycogen, magnesium ascorbyl phosphate, cetyl alcohol, dimethicone, isopropyl myristate and glycerol.

### Claim 12 (depends on 1)

The method of claim 1, wherein the composition comprises butyric acid, glucose, glycogen, magnesium ascorbyl phosphate, propylene glycol, Quaternium-52 and ethanol.

### Claim 13 (depends on 1)

The method of claim 1, wherein the pH of the composition is between 3 and 6.

### Claim 14 (depends on 1)

The method of claim 1, further comprising administering one or more anti-seborrhoeic agents.

### Claim 15 (depends on 1)

The method of claim 1, wherein the composition and the anti-seborrhoeic agent are administered sequentially.

### Claim 16 (depends on 1)

The method of claim 1, wherein the composition and the anti-seborrhoeic agent are administered simultaneously.
